"Revolutionary Cough Relief: Levocloperastine 35.4mg Suspension"

Mar 14, 2024

RAPIDKOF LINCTUS SUSPENSION 

Levocloperastine Fendizoate (35.4mg) Oral Suspension

Levocloperastine Fendizoate Oral Suspension: An Overview

Levocloperastine Fendizoate oral suspension, often found in products like RAPIDKOF LINCTUS SUSPENSION, represents a significant advancement in the treatment of cough. This pharmaceutical solution is designed to offer symptomatic relief from both dry and productive coughs, ensuring comfort and faster recovery for patients across various age groups. The active ingredient, Levocloperastine Fendizoate (35.4mg), is the cornerstone of its effectiveness, providing a dual-action mechanism that addresses cough at its root.

Key Components and Their Roles

  • Levocloperastine Fendizoate (35.4mg): The primary active ingredient, renowned for its antitussive (cough suppressing) and mucolytic (mucus thinning) properties. It works by reducing the cough reflex and facilitating the expulsion of mucus.

Mechanism of Action

  • Dual-Action Approach: Levocloperastine acts on the cough center in the brain to suppress cough reflexes and on the respiratory tract to thin out mucus, making it easier to expel.

Indications for Use

  • Broad Spectrum Efficacy: Suitable for treating both dry and productive coughs, making it a versatile option for patients experiencing various types of cough.

Dosage and Administration

  • Convenient Oral Suspension Form: The suspension is easy to administer and is typically dosed according to the patient's age and weight, ensuring a tailored approach to cough treatment.

Advantages Over Other Cough Treatments

  • Efficacy: Offers rapid relief from cough symptoms, improving patient comfort and reducing the duration of cough episodes.
  • Safety Profile: Generally well tolerated by most patients, with a low incidence of side effects compared to other cough medications.

Considerations and Precautions

  • Consultation with Healthcare Provider: It's crucial for patients to consult their healthcare provider before starting any new medication, including this oral suspension, to ensure it's appropriate for their specific health condition.

Conclusion

Levocloperastine Fendizoate oral suspension, with its active component of 35.4mg, presents a significant step forward in cough management. Its dual-action mechanism provides effective relief for both dry and productive coughs, making it a versatile and essential medication in the respiratory treatment landscape. As with any medication, consultation with a healthcare provider is paramount to ensure its suitability and to maximize its benefits while minimizing potential risks.  A group of highly skilled pharmaceutical professionals founded a specialist pharmaceutical in February 2018 such as Steris Healthcare Pvt Ltd.Sterispharma is a WHO, GMP, and ISO-certified pharma company based in Navi Mumbai. They provide quality medicines at the best price to customers in India as per the standard parameters of WHO. With a steris online pharmacy, you can buy and get home delivery of medicines at your doorsteps. Our main goal at Steris is to provide a wide range of healthcare goods to meet the various needs of the healthcare sector. Steris is dedicated to satisfying the needs of the healthcare industry, whether it be with regard to specialty treatments, rare disease meds, or necessary pharmaceuticals. Steris healthcare products range covers almost every cadre of requirement in today's Medical scenario, widely prescribed under categories like Cardiology, Asthama, Respiratory, Nasal, Diabetic, Endocrinology, Cadiology, Gastrology, Orthopaedic, Anti-infective/antibiotic, General, Urology, Neurology, Nephrology, Oncology, Gynaecology, Pediatric, Dental & Derma range of Products.

For further more information:

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com    

CALL:: 7877551268, 8209542042, 8955945010, 6377716668   

WHATSAPP:: MONA, HARSHITA, SAKSHI, SHWETA   

BUY NOW

 

 

 

 

 

SHARE WITH